**To the Editor**We greatly enjoyed reading the recently published article by Kim et al. ([@B1]). The authors found that the serum D-dimer levels were significantly associated with left atrial enlargement in anticoagulation-naïve patients with acute ischemic stroke and non-valvular atrial fibrillation. A number of studies have indicated the role of D-dimer in the stroke diagnosis, progression, and mortality ([@B2],[@B3]). Plasma D-dimer levels, due to their good correlation with the prognosis of acute stroke according to previous studies and their early and easy availability, have been shown to be a good candidate biomarker for the prognosis of acute stroke ([@B2],[@B3]). Brain natriuretic peptide (BNP) is also frequently elevated after an acute stroke and has been shown to be an independent predictor of mortality and a biological marker for distinguishing cardioembolic stroke from other stroke sub-types ([@B4]). Tamura et al. suggested that elevated plasma BNP concentrations may be a reliable surrogate marker for the prediction of left atrial appendage dysfunction and cardiogenic stroke in patients with acute ischemic stroke ([@B5]). Rost et al. also showed that elevated BNP was associated with a lower ejection fraction and left atrial dilatation in patients with acute ischemic stroke ([@B6]). We would therefore be grateful if the authors would provide the data for BNP levels on admission and their relationship with the serum D-dimer levels in patients with acute ischemic stroke.
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